Annamaria Gullà

3.4k total citations
53 papers, 2.1k citations indexed

About

Annamaria Gullà is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Annamaria Gullà has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Hematology and 19 papers in Cancer Research. Recurrent topics in Annamaria Gullà's work include Multiple Myeloma Research and Treatments (28 papers), RNA Interference and Gene Delivery (13 papers) and Protein Degradation and Inhibitors (13 papers). Annamaria Gullà is often cited by papers focused on Multiple Myeloma Research and Treatments (28 papers), RNA Interference and Gene Delivery (13 papers) and Protein Degradation and Inhibitors (13 papers). Annamaria Gullà collaborates with scholars based in United States, Italy and Czechia. Annamaria Gullà's co-authors include Pierfrancesco Tassone, Maria Teresa Di Martino, Pierosandro Tagliaferri, Kenneth C. Anderson, Nicola Amodio, Eugenio Morelli, Michele Caraglia, Antonino Neri, Gabriella Misso and Emanuela Leone and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Annamaria Gullà

49 papers receiving 2.1k citations

Peers

Countries citing papers authored by Annamaria Gullà

Since Specialization

Citations

This map shows the geographic impact of Annamaria Gullà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annamaria Gullà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annamaria Gullà more than expected).

Fields of papers citing papers by Annamaria Gullà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annamaria Gullà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annamaria Gullà. The network helps show where Annamaria Gullà may publish in the future.

Co-authorship network of co-authors of Annamaria Gullà

This figure shows the co-authorship network connecting the top 25 collaborators of Annamaria Gullà. A scholar is included among the top collaborators of Annamaria Gullà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annamaria Gullà. Annamaria Gullà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Alice Bartolini, Daniela Cantarella, (unknown), Annamaria Gullà, Elena Grassi, Chiara Lazzari, Marco Rubatto, Vanesa Gregorc, Fabrizio Carnevale‐Schianca, Martina Olivero, Federico Bussolino, Valentina Comunanza	0
2	DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy 2024 ·Antioxidants and Redox Signaling ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kenneth C. Anderson, Annamaria Gullà	4
3	Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), David Žihala, (unknown), Alexander Vdovin, (unknown), Tereza Ševčíková, Zuzana Chyra, Tomáš Jelı́nek, Michal Šimíček, Annamaria Gullà, Kenneth C. Anderson, Roman Hájek, Matouš Hrdinka	11
4	BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma 2023 ·Clinical Cancer Research ·Keiji Kurata, Mehmet Samur, (unknown), Kenneth Wen, (unknown), Jiye Liu, Eugenio Morelli, Annamaria Gullà, Yu‐Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C. Anderson	19
5	Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation 2021 ·Blood Cancer Discovery ·Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, (unknown), Rao Prabhala, Srikanth Talluri, Kenneth Wen, Yu‐Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi, Kenneth C. Anderson	92
6	ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment 2021 ·Blood Cancer Discovery ·Giada Bianchi, Peter G. Czarnecki, Matthew Ho, Aldo M. Roccaro, Antonio Sacco, Yawara Kawano, Annamaria Gullà, Anıl Aktaş Samur, (unknown), Kenneth Wen, Yu‐Tzu Tai, (unknown), Xinchen Wu, Gulden Camci‐Unal, Matteo Da Vià, Niccolò Bolli, Tomasz Sewastianik, Ruben D. Carrasco, Irene M. Ghobrial, Kenneth C. Anderson	12
7	Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities 2021 ·Frontiers in Oncology ·(unknown), Nicola Amodio, Annamaria Gullà, Kenneth C. Anderson	29
8	CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 2021 ·Methods in molecular biology ·Eugenio Morelli, Annamaria Gullà, Nicola Amodio, Elisa Taìana, Antonino Neri, Mariateresa Fulciniti, Nikhil C. Munshi	16
9	The Non-Coding RNA Landscape of Plasma Cell Dyscrasias 2020 ·Cancers ·Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, (unknown), Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone, Nicola Amodio	25
10	Multiple myeloma: the (r)evolution of current therapy and a glance into future 2020 ·Haematologica ·Annamaria Gullà, Kenneth C. Anderson	82
11	Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease 2017 ·Blood ·Marco Rossi, Emanuela Altomare, Nicola Amodio, Maria Teresa Di Martino, Marco Gaspari, Domenico Taverna, Domenica Scumaci, Francesco Conforti, Daniele Caracciolo, Cirino Botta, Cinzia Federico, Annamaria Gullà, Eugenio Morelli, Francesca Scionti, Mariamena Arbitrio, (unknown), Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone	2
12	Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma 2016 ·Molecular Cancer Therapeutics ·Nicola Amodio, Maria Angelica Stamato, Annamaria Gullà, Eugenio Morelli, Enrica Romeo, Lavinia Raimondi, Maria Rita Pitari, Ida Ferrandino, Gabriella Misso, Michele Caraglia, Ida Perrotta, Antonino Neri, Mariateresa Fulciniti, Christian Rolfo, Kenneth C. Anderson, Nikhil C. Munshi, Pierosandro Tagliaferri, Pierfrancesco Tassone	96
13	Mir-221/222 are promising targets for innovative anticancer therapy 2016 ·Expert Opinion on Therapeutic Targets ·Maria Teresa Di Martino, Marco Rossi, Daniele Caracciolo, Annamaria Gullà, Pierosandro Tagliaferri, Pierfrancesco Tassone	41
14	A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 2015 ·Clinical Cancer Research ·Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, (unknown), Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	97
15	Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 2015 ·Leukemia ·Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio, Maria Teresa Di Martino, Nicola Amodio, Lavinia Biamonte, Annamaria Gullà, Umberto Foresta, Maria Rita Pitari, Cirino Botta, Marco Rossi, Antonino Neri, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	93
16	In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma 2014 ·PLoS ONE ·Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, Maria Eugenia Gallo Cantafio, Annamaria Gullà, Umberto Foresta, Pietro Hiram Guzzi, M. A. Castellano, Anna Grimaldi, Vincenzo Gigantino, Renato Franco, Sara Lusa, Mario Cannataro, Pierosandro Tagliaferri, Giuseppe De Rosa, Pierfrancesco Tassone, Michele Caraglia	93
17	In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells 2014 ·PLoS ONE ·Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Emanuela Altomare, Nicola Amodio, Emanuela Leone, Eugenio Morelli, (unknown), Daniele Caracciolo, Marco Rossi, Niels Frandsen, Pierosandro Tagliaferri, Pierfrancesco Tassone	74
18	Mir-34: A New Weapon Against Cancer? 2014 ·Molecular Therapy — Nucleic Acids ·Gabriella Misso, Maria Teresa Di Martino, Giuseppe De Rosa, Ammad Ahmad Farooqı, Angela Lombardi, Virginia Campani, Mayra Rachele Zarone, Annamaria Gullà, Pierosandro Tagliaferri, Pierfrancesco Tassone, Michele Caraglia	420
19	Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities 2014 ·Frontiers in Oncology ·Cirino Botta, Annamaria Gullà, Pierpaolo Correale, Pierosandro Tagliaferri, Pierfrancesco Tassone	54
20	Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 2013 ·Clinical Cancer Research ·Emanuela Leone, Eugenio Morelli, Maria Teresa Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	184

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact